Connection

Donna Mancini to Glucosides

Back to Details
This is a "connection" page, showing publications Donna Mancini has written about Glucosides.
Donna Mancini
Connection Strength
0.138
Glucosides
  1. Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity? Cardiovasc Drugs Ther. 2019 02; 33(1):87-95.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.